Over 150 Indian Companies to Showcase at UBM India's PharmaLytica 2016

Wednesday, July 13, 2016 Indian Health News
Email Print This Page Comment bookmark
Font : A-A+

HYDERABAD, India, July 13, 2016 /PRNewswire/ --

India's Most Comprehensive Analytical, Lab, Pharma Machinery

and Contract Services Event 

UBM India, organisers of CPhI and P-MEC India, the leading global pharma trade show and conference, today announced the 3rd edition of Pharmalytica 2016. The two day expo will be held at the HITEX Exhibition Center in Hyderabad

on 5th and 6th August 2016.

     (Logo: http://photos.prnewswire.com/prnh/20160713/10150475  )

     (Logo: http://photos.prnewswire.com/prnh/20130226/599595-c  )

Backed by proven expertise of growing businesses in India's Pharma sector, PharmaLytica is an ideal platform for the Pharma Industry experts from Analytical and Bio Tech, Lab equipments and Lab Chemicals, Pharma Machinery and Outsourcing Solutions background. The expo will be held in the rich and conducive pharmaceutical capital of India, Hyderabad, which is considered to be the best bulk drug hub in the country and accounts for nearly a fifth of India's exports of drugs. Through an entire range of sessions and discussions as part of the PharmaLytica conference, the event will help the Pharmaceutical community keep updated with the latest industry trends and innovations pertaining to the analytical, biotechnology, laboratory, pharma machinery and outsourcing services sector.

The 3rd edition of PharmaLytica will see participation from over 150 exhibitors from across the country. Few major participants include, Ingersoll Rand India Ltd., Kirloskar Pneumatic Co. Ltd., Chemipack India Pvt. Ltd., Shiv Shakti Process Equipment P. Ltd., GMP Technical Solutions Pvt. Ltd., Integrated Cleanroom Technology Pvt. Ltd., Galaxy Sivtek Pvt. Ltd., First Source Laboratory Solutions, Osworld Scientific Equipments Pvt. Ltd., Charles River Laboratories India Pvt. Ltd., Humidity Technologies Pvt. Ltd., Jay Instruments & Systems Pvt. Ltd., Daicel Chiral Technologies (India) Pvt. Ltd., Scientific Research Instruments Company Private Limited and Sefar India Private Limited amongst others.

Commenting on the announcement of the 3rd edition of the expo, Mr. Yogesh Mudras, Managing Director, UBM India said, " We are delighted to announce the third edition of PharmaLytica in the bulk drug capital of India. The event is intended to become one of the primary marketplaces for products and services along the entire value chain in niche segments within the Pharma industry. PharmaLytica will not only enable the exhibitors and visitors to network and connect but will also help the Pharma community to pick up the latest industry trends and inventions pertaining to the analytical, laboratory, pharma machinery, biotechnology and outsourcing services sectors."

Key sessions at PharmaLytica 2016, will cover subjects that encompass new trends and insights relating to the sector at large. The topics of the sessions include, 'Status and Trend of Global Innovative Drugs - The Power of Partnerships and Alliances', 'Contemporary Clinical Trials - Issues and Concerns', 'Good Pharmacovigilance Practice', 'Introduction to GMP Regulations for a Laboratory', 'Converting Pharmaceutical innovation into sustainable productivity', 'Diagnostic Clinics - Role of Real World Data', 'Advancements and Impacts of Analytical and Bioanalytical Techniques', 'Advances in Chromatography and Mass Spectrometry', 'nSMOL: Simplifying mAb Quantitation' and 'Laboratory Analytical Market - Statusquo and Future'.

The sessions will have some prominent names from the industry such as Dr. Akhilesh Sharma, Chief Medical Officer and Global Head, Dr Reddy's Laboratories Limited; Dr. Ambrish Srivastava, Vice President - Medical Affairs, Clinical Research and Regulatory, Alkem Labs Ltd.; Dr. Ajoy Roy, Senior Medical Director, Head India Medical Services, Parexel International (India) Pvt. Ltd., Dr. Deepa Arora, Vice President- Pharmacovigilance and Global Head - Drug Safety and Risk Management, Lupin Limited; Mr. Santosh Shevade, CSE Group Head, Clinical Development, Novartis Healthcare Pvt. Ltd.;Dr. Rashmi Hegde, Director - Medical, Abbott Healthcare India Limited; Dr. Sharad Mankumare, Director of Reference Standard Laboratory, United States of Pharmacopeia (USP), Hyderabad; Dr. Hemant Borgaonkar, Technical Consultant, Labindia.

To know more about the event and register for a free entry to the event, visit:http://www.ubmindia.in/pharmalytica

About UBM India: 

UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences and seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia.

For further details, please visit:ubmindia.in

Media Contact: Mili Lalwani mili.lalwani@ubm.com +91-22-61727000 UBM India


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store